![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
TJ Resink, T Scott-Burden, C Boulanger, E Weber and FR Buhler
Department of Research, University Hospital, Basel, Switzerland.
The binding and internalization of 125I-endothelin (125I-ET-1) was studied in cultured human vascular smooth muscle cells (hVSMC). Discrimination between surface-bound and internalized radiolabeled ligand was achieved using either acetic acid or trypsin treatment of cell layers, with the two procedures yielding comparable results. Total cellular 125I-ET-1 binding hVSMC at 37 degrees was rapid and reached near equilibrium within 30 min. Such binding could be resolved into surface-bound (acid/trypsin-sensitive) and internalized (acid/trypsin- resistant) components. The accumulation of internalized 125I-ET-1 was temperature dependent and occurred at 37 degrees (t1/2 approximately 15 min) but not at 4 degrees. Internalization of 125I-ET-1 by hVSMC was reversibly inhibited by the transglutaminase inhibitor dansylcadaverine (half-maximal inhibitory concentration, approximately 400 microM). Cytosolic acidification of hVSMC (from pH approximately 6.8 to approximately 6.3) by incubation with potassium acetate in a choline buffer also inhibited 125I-ET-1 internalization. Our observation indicate that smooth muscle cells internalize ET-1 via the clathrin- mediated endocytotic pathway. Dansylcadaverine and other inhibitors of transglutaminase inhibited ET-1-stimulated inositol phospholipid hydrolysis in hVSMC and decreased ET-1-induced vasoconstriction in isolated endothelium-denuded blood vessels. Internalization of ET-1 may, therefore, be relevant to the characteristically protracted physiological effects of this peptide on the vasculature.
This article has been cited by other articles:
|
|
 |
|
  M. Tosun, Y. Erac, C. Selli, and N. Karakaya Sarcoplasmic-endoplasmic reticulum Ca2+-ATPase inhibition prevents endothelin A receptor antagonism in rat aorta Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1961 - H1966. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Okafor, P. Mukhopadhyay, and N. A. Delamere Studies on Endothelin Release and Na,K Transport in Porcine Lens Invest. Ophthalmol. Vis. Sci., March 1, 2002; 43(3): 790 - 796. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Tchekneva, M. L. Lawrence, and B. Meyrick Cell-specific differences in ET-1 system in adjacent layers of main pulmonary artery. A new source of ET-1 Am J Physiol Lung Cell Mol Physiol, April 1, 2000; 278(4): L813 - L821. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. RUSCHITZKA, S. SHAW, D. GYGI, G. NOLL, M. BARTON, and T. F. LÜSCHER Endothelial Dysfunction in Acute Renal Failure: Role of Circulatingand Tissue Endothelin-1 J. Am. Soc. Nephrol., May 1, 1999; 10(5): 953 - 962. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Schutze, T. Machleidt, D. Adam, R. Schwandner, K. Wiegmann, M.-L. Kruse, M. Heinrich, M. Wickel, and M. Kronke Inhibition of Receptor Internalization by Monodansylcadaverine Selectively Blocks p55 Tumor Necrosis Factor Receptor Death Domain Signaling J. Biol. Chem., April 9, 1999; 274(15): 10203 - 10212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Ferrari, A. Talbodec, P. Vigne, and C. Frelin Evidence for receptor bound endothelin in renal but not in cardiac tissues from normal rats Cardiovasc Res, April 1, 1998; 38(1): 140 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. VERKHRATSKY, R. K. ORKAND, and H. KETTENMANN Glial Calcium: Homeostasis and Signaling Function Physiol Rev, January 1, 1998; 78(1): 99 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ravalli, M. Szabolcs, A. Albala, R. E. Michler, and P. J. Cannon Increased Immunoreactive Endothelin-1 in Human Transplant Coronary Artery Disease Circulation, November 1, 1996; 94(9): 2096 - 2102. [Abstract] [Full Text]
|
|
|
|
|
|
A. M. Zeiher, H. Goebel, V. Schachinger, and C. Ihling Tissue Endothelin-1 Immunoreactivity in the Active Coronary Atherosclerotic Plaque : A Clue to the Mechanism of Increased Vasoreactivity of the Culprit Lesion in Unstable Angina Circulation, February 15, 1995; 91(4): 941 - 947. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
